Pathstone Family Office’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$262K Sell
1,642
-2,087
-56% -$467K ﹤0.01% 1368
2023
Q2
$1.08M Sell
3,729
-8
-0.2% -$2.43K 0.02% 460
2023
Q1
$1.19M Buy
3,737
+1,201
+47% +$356K 0.02% 403
2022
Q4
$736K Sell
2,536
-740
-23% -$204K 0.01% 924
2022
Q3
$752K Buy
3,276
+2,269
+225% +$568K 0.01% 883
2022
Q2
$219K Hold
1,007
﹤0.01% 926
2022
Q1
$268K Sell
1,007
-458
-31% -$112K 0.01% 792
2021
Q4
$389K Sell
1,465
-182
-11% -$52.8K 0.01% 633
2021
Q3
$468K Buy
1,647
+322
+24% +$91.8K 0.01% 543
2021
Q2
$364K Buy
1,325
+525
+66% +$143K 0.01% 576
2021
Q1
$209K Buy
+800
New +$214K 0.01% 598
2020
Q1
Sell
-296
Closed -$507K 814
2019
Q4
$507K Buy
+296
New +$49.3K 0.01% 295
2014
Q4
Sell
-38
Closed -$1K 221
2014
Q3
$1K Buy
+38
New +$1.39K ﹤0.01% 308
2014
Q2
Sell
-37
Closed -$2K 171
2014
Q1
$2K Buy
+37
New +$1.64K 0.01% 155
2013
Q4
Sell
-318
Closed -$12K 308
2013
Q3
$12K Buy
+318
New +$10.7K 0.05% 170

Other funds holding PODD

Pathstone Family Office's PODD Position: Q3 2023 in Review

Pathstone Family Office reduced its Insulet (PODD) stake by 56% in Q3 2023, selling an estimated $467K and leaving 1,642 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.

Pathstone Family Office first reported a position in PODD in Q3 2013 and has held it in 15 quarters since. The position peaked at $1.19M in Q1 2023. 528 funds tracked by Wall St. Rank hold PODD as of Q3 2023.

  • Pathstone Family Office held 1,642 shares of Insulet worth $262K as of Q3 2023.
  • Pathstone Family Office sold 2,087 Insulet shares in Q3 2023, an estimated $467K.
  • Insulet made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1368 holding.
  • Pathstone Family Office first reported a position in Insulet in Q3 2013 and has held it in 15 quarters since.
  • Pathstone Family Office's Insulet position peaked at $1.19M in Q1 2023.
  • 528 funds tracked by Wall St. Rank held Insulet as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.